In vivo assays showed that overexpression of PABPN1 in BC cells significantly reduced tumor volume and weight of the subcutaneous xenografts, while knockdown of PABPN1 increased the tumor-initiating ability of BC cells (Fig. 2D–F). This evidence concerns the gene PABPN1 and breast cancer.